ResMed to Webcast First Quarter 2008 Earnings Confe... ( SAN DIEGO Oct. 19 /- RESMED INC. ...)

ResMed to Webcast First Quarter 2008 Earnings Conference Call

Date:10/19/2007

SAN DIEGO, Oct. 19 /PRNewswire-FirstCall/ -- RESMED INC. (NYSE: RMD), announced today that on Thursday, November 1, 2007, it will release its earnings for this first quarter of fiscal year 2008, ended September 30, 2007. ResMed will issue an earnings press release after 1:00 p.m. Pacific Time and will host a conference call to review its quarterly results, market trends, and future outlook.

The conference call is scheduled to begin at 2:00 p.m. Pacific Time and will be webcast on ResMed's website at http://www.resmed.com. The online archive of the broadcast will be available approximately 30 minutes after the live call and will continue to be available for two weeks.

International conference call times will be:

9:00 p.m. London

8:00 a.m. Sydney, Australia (November 2, 2007)

TO PARTICIPATE in the conference call, please call one of the below numbers at least 10 minutes before the call begins and identify yourself to the operator:

Domestic: 800-591-6945

International: 617-614-4911

Conference Name: ResMed Inc. 1Q 2008 Earnings Call

Participant Passcode: 12441080

The replay of the conference call will be available approximately 30 minutes after the call and will be accessible for two weeks at:

Domestic: 888-286-8010

International: 617-801-6888

Passcode: 92500400

ResMed is a leading manufacturer of medical equipment for the treatment and management of sleep-disordered breathing and other respiratory disorders. Further information can be obtained by contacting Matthew Borer at ResMed Inc. at +1 (858) 746-2280, or by visiting the Compa
'/>"/>

SOURCE ResMed Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. First Vaccine Designed for Africa Cleared for Testing in Humans
2. Infant receives first bloodless liver transplant
3. Oracle Corp. to help build worlds first "Digital Hospital"
4. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
5. First human clone is near
6. First Artificial Heart patient has Major setback
7. FDA approves first pocket-sized EKG machine
8. First head-to-head trials of once weekly Fosamax and Actonel therapies
9. WHO Declares Vietnam First Country to Control SARS
10. Russia Reports First SARS Case
11. Hope for First New Melanoma Treatment in Decades

Post Your Comments:

(Date:12/6/2009)... NEW ORLEANS, Dec. 6 Sickle cell ... red blood cells, is one of the most ... around the world, including more than 70,000 Americans.(1) ... of the American Society of Hematology highlights intriguing ... pandemic presents for children with this blood disorder, ...

(Date:12/6/2009)... Joseph W. Belluck of Belluck & Fox, LLP says dangerous substances ... seasons. , ... New York, NY (PRWEB) December 6, ... season, they should be alert to reports of recalls due to ... lawyer., , ,“Close to 230,000 children visit hospital emergency rooms each ...

(Date:12/5/2009)... Type of Blood Cancer Is Most Challenging-- ... oncologists have identified specific genes, dubbed partner genes, that ... of leukemia in infants. By more accurately defining specific ... may benefit from particular treatments. ,, Oncologists also ...

(Date:12/5/2009)... the launch of International Solutions, an innovative new international private medical ... equivalent. In addition to offering customers the flexibility to add or ... budgets, International Solutions enables customers to tailor their benefits to complement ... , ...

(Date:12/4/2009)... LLP employees came together in more than 90 offices nationwide ... the audit, tax and advisory firm,s support for literacy with ... firm,s long history of volunteerism. Instead of holiday parties, our ... holidays for some children," said Tim Flynn, Chairman of KPMG. ...

[0] Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease [0] Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season [0] New Gene Findings Will Help Guide Treatment in Infant Leukemia [0] AVIVA's Private Health Insurance Products Solutions Go International [0] KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children

... Dec. 4, 2007 The High School Musical Rockerz Jammin ... be what kids want most this holiday season, but if ... are used, a season of joy might turn into a ... measuring the loudness of many desired toys, University of California, ...

... In response to the growing body of research ... for Cancer Research (AACR) announces the launch of a ... submissions of papers. This important new journal is the ... from preclinical research to clinical trials. , In the ...

... Our belief in power hierarchies is important in how ... a dissertation by Alexandra Snellman from Uppsala University that ... and ethnic discrimination in various situations. , Discrimination and ... our prejudices but are affected by other factors as ...

... idea that only vertebrates have sophisticated adaptive immune systems ... after being infected by them just once has been ... insects also have a form of immune memory that ... previously encountered. This was just one of the striking ...

... with Millions of Transactions, TAMPA, Fla., ... an,esteemed list of petitioners urging the White ... regulations which prohibit controlled drugs from being,electronically ... e-Prescribing,Controlled Substances Coalition, such regulations are negatively ...

... Make Life Easier for Double Amputee, MEDIA ADVISORY ... Thomas Graham, 24, recent Iraqi War Veteran and,double amputee, ... Baltimore,location, WHAT: The delivery of a special birthday ... of both legs while deployed in Iraq,nothing is deterring ...

Other Medicine News:Health News:Greater parental guidance suggested for noisy toy use 2 Health News:AACR introduces Cancer Prevention Research 2 Health News:AACR introduces Cancer Prevention Research 3 Health News:Ethnic discrimination not only based on prejudice 2 Health News:Violent sex acts boost insect's immunity system 2 Health News:Violent sex acts boost insect's immunity system 3 Health News:Sage Software Joins e-Prescribing Coalition for Presidential Petition 2 Health News:Sage Software Joins e-Prescribing Coalition for Presidential Petition 3

Greater parental guidance suggested for noisy toy use AACR introduces Cancer Prevention Research Ethnic discrimination not only based on prejudice Violent sex acts boost insect's immunity system Sage Software Joins e-Prescribing Coalition for Presidential Petition The SCOOTER Store Donates Power Wheelchair as a Birthday Gift to Iraqi War Hero

(Date:12/4/2009)... 4 PharmAthene, Inc. (NYSE Amex: PIP ... biological and chemical threats, announced today that the ... the effectiveness of Valortim® in an inhalation anthrax ... The data are being presented during an ...

(Date:12/4/2009)... 4 Axsun Technologies, Inc., a wholly-owned subsidiary of ... initial development and successful testing of a novel integrated ... this proprietary optical engine design raises the bar on ... for swept source OCT light sources. This approach ...

(Date:12/4/2009)... 4 Watson Pharmaceuticals, Inc. (NYSE: WPI ... that its subsidiary, Watson Laboratories, Inc.-Florida, filed an Abbreviated ... Drug Administration seeking approval to market its 8mg ramelteon ... by Takeda Pharmaceutical Company Limited. Watson,s 8mg ramelteon ...

Breaking Medicine Technology:PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2 PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3 PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4 PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5 PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6 Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2 Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3 Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4 Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5 Watson Files FDA Application for Generic Rozerem(R) 2 Watson Files FDA Application for Generic Rozerem(R) 3 Results From Drug Trials and New Risk Factors Announced at International Alzheimers Conference 4725 1 Results From Drug Trials and New Risk Factors Announced at International Alzheimers Conference 4725 2 Results From Drug Trials and New Risk Factors Announced at International Alzheimers Conference 4725 3 Results From Drug Trials and New Risk Factors Announced at International Alzheimers Conference 4725 4 Results From Drug Trials and New Risk Factors Announced at International Alzheimers Conference 4725 5 Results From Drug Trials and New Risk Factors Announced at International Alzheimers Conference 4725 6 Board Certified Cardiologist Dr Stephen Sinatra Featured on Searchjointpain com 51730 1 Board Certified Cardiologist Dr Stephen Sinatra Featured on Searchjointpain com 51730 2 Reviews of microbial gene language published in special issue of Trends in Microbiology 9269 1 Reviews of microbial gene language published in special issue of Trends in Microbiology 9269 2 Reviews of microbial gene language published in special issue of Trends in Microbiology 9269 3 Reviews of microbial gene language published in special issue of Trends in Microbiology 9269 4

[0] PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop [0] Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging [0] Watson Files FDA Application for Generic Rozerem(R)

... MKC-1 Akt-mTOR Inhibitor Mechanism, ROCKVILLE, Md., ... ), a clinical-stage pharmaceutical company developing,therapeutics for ... today,announced the presentation of results for its ... carcinoma (RCC) models. The results were,presented at ...

... Significant Efficacy Within One ... Week of Daily ... Nasdaq:,SHPGY, TSX: SHQ), the global specialty biopharmaceutical company, today,announced the ... Hyperactivity Disorder (ADHD) experienced significant,improvements in ADHD symptom control within ...

Other Medicine Technology:EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model 2 EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model 3 EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model 4 Results of VYVANSE(TM) (lisdexamfetamine dimesylate) Pivotal Trial in Adult ADHD Presented at Major Scientific Meeting 2 Results of VYVANSE(TM) (lisdexamfetamine dimesylate) Pivotal Trial in Adult ADHD Presented at Major Scientific Meeting 3 Results of VYVANSE(TM) (lisdexamfetamine dimesylate) Pivotal Trial in Adult ADHD Presented at Major Scientific Meeting 4 Results of VYVANSE(TM) (lisdexamfetamine dimesylate) Pivotal Trial in Adult ADHD Presented at Major Scientific Meeting 5 Results of VYVANSE(TM) (lisdexamfetamine dimesylate) Pivotal Trial in Adult ADHD Presented at Major Scientific Meeting 6

EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model Results of VYVANSE(TM) (lisdexamfetamine dimesylate) Pivotal Trial in Adult ADHD Presented at Major Scientific Meeting

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

Medicine Products:

Dyazide, Urine Ductal Lavage, Breast Ductal Lavage Drugs of Abuse Confirmation/Quantitation-Propoxyphene & Metabolite-Urine Drugs of Abuse Confirmation/Quantitation-Phencyclidine-Serum or Plasma

ResMed to Webcast First Quarter 2008 Earnings Confe...( SAN DIEGO Oct. 19 /- RESMED INC. ...),Health